We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+4.93%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$18.3B
AUM Growth
+$1.89B
Cap. Flow
+$1.14B
Cap. Flow %
6.21%
Top 10 Hldgs %
51.34%
Holding
5,202
New
442
Increased
1,708
Reduced
1,323
Closed
403

Sector Composition

Rank Sector Weight
1 Financials 5.2%
2 Energy 5.01%
3 Technology 3.76%
4 Healthcare 2.35%
5 Communication Services 2.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBFC
4901
DELISTED
Village Bank and Trust Financial Corp.
VBFC
-600
Closed -$16K
CUTR
4902
DELISTED
Cutera, Inc.
CUTR
$0 ﹤0.01%
17
VIRX
4903
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
-143
Closed -$18K
NDP
4904
DELISTED
TORTOISE ENERGY INDEPENDENCE FUND, INC.
NDP
-1,339
Closed -$177K
SEEL
4905
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
0
-$1K
VTNR
4906
DELISTED
Vertex Energy, Inc
VTNR
$0 ﹤0.01%
10
-1,049
-99% -$1.39K
DXYN
4907
DELISTED
Dixie Group Inc
DXYN
-1,200
Closed -$4K
PRFT
4908
DELISTED
Perficient Inc
PRFT
-166
Closed -$3K
HOLI
4909
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
-100
Closed -$2K
OSG
4910
DELISTED
Overseas Shipholding Group Inc.
OSG
$0 ﹤0.01%
36
SCPX
4911
DELISTED
Scorpius Holdings, Inc.
SCPX
0
-$3K
CMLS
4912
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$0 ﹤0.01%
100
-750
-88% -$613
GENE
4913
DELISTED
Genetic Technologies Ltd.
GENE
$0 ﹤0.01%
10
TTOO
4914
DELISTED
T2 Biosystems, Inc
TTOO
0
-$9K
EIGR
4915
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
0
SCTL
4916
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
-558
Closed -$4K
CBAY
4917
DELISTED
Cymabay Therapeutics
CBAY
-4,000
Closed -$7K
NSTG
4918
DELISTED
NanoString Technologies, Inc.
NSTG
-1,802
Closed -$40K
NVTA
4919
DELISTED
Invitae Corporation
NVTA
-700
Closed -$6K
ONCT
4920
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
-3
Closed -$2K
FRTX
4921
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
0
GHL
4922
DELISTED
Greenhill & Co., Inc.
GHL
$0 ﹤0.01%
9
ICPT
4923
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-100
Closed -$1K
GER
4924
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
-56
Closed -$4K
FIHD
4925
DELISTED
UBS AG FI Enhanced Global High Yield ETN
FIHD
-258
Closed -$32K

Similar funds

Creative Planning's Q1 2017 Portfolio in Review

As of Q1 2017, Creative Planning held 5,202 positions worth $18.3B, up 12% from $16.4B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Creative Planning deployed $1.14B of net new capital in Q1 2017, opening 442 new positions and adding to 1,708 existing holdings. Its largest new stake was Skywest: 37,415 shares worth $1.28M.

By sector, the portfolio is most concentrated in Financials at 5.2% of assets, down from 5.4% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Summit Materials, Inc. Class A Common Stock, an estimated $20.2M trimmed.

  • Creative Planning's largest Q1 2017 buy was Skywest: 37,415 shares worth $1.28M.
  • Creative Planning added most to Vanguard Intermediate-Term Corporate Bond ETF in Q1 2017, an estimated $147M increase.
  • Creative Planning's biggest Q1 2017 reduction was Summit Materials, Inc. Class A Common Stock, cutting an estimated $20.2M.
  • Creative Planning fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $3.07M.
  • Creative Planning's ten largest holdings make up 51% of its $18.3B portfolio in Q1 2017.
  • Creative Planning opened 442 new positions and closed 403 in Q1 2017.
  • Creative Planning's portfolio value rose 12% quarter-over-quarter to $18.3B.

Based on Creative Planning's 13F filing for Q1 2017, filed 7 Apr 2017.